Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Intratumoral dose heterogeneity promotes adaptive anti-tumor immunity and predicts clinical response to radiopharmaceutical therapy.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Image optimization for low-dose 18F-FDG breast PET/MRI using deep learning: a pilot study.
Journal: EJNMMI physics
Published: December 30, 2025
Implementation of a Multidisciplinary Radiopharmaceutical Dosimetry Program: Key Practical Considerations and Challenges.
Journal: Practical radiation oncology
Published: December 02, 2025
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 04, 2025
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network.
Journal: Radiology. Artificial intelligence
Published: February 19, 2025
Functional Imaging of Changes in Lung Function Before and After Radiation Therapy of Lung Cancer.
Journal: Advances in radiation oncology
Published: February 15, 2025
Uncertainty quantification for deep learning-based metastatic lesion segmentation on whole body PET/CT.
Journal: Physics in medicine and biology
Published: December 11, 2024
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT.
Journal: Journal of clinical medicine
Published: August 22, 2024
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: August 14, 2024
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.
Journal: ArXiv
Published: April 25, 2024
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 19, 2024
Last Updated: 09/26/2026